¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"The Dhaka University studies. Part B."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alveolar soft part sarcoma
    Æ÷»ó¿¬ºÎÀ°Á¾
  • maternal part
    ¸ðüºÎºÐ
  • opercular part
    µ¤°³ºÎºÐ
  • presenting part
    ¼±ÁøºÎ
  • part
    ºÎºÐ, ºÎ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • part
    ºÎºÐ, ºÎ
  • presenting part
    ¼±ÁøºÎ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maternal part
    ¸ðüºÎºÐ
  • opercular part
    µ¤°³ºÎºÐ
  • part
    ºÎºÐ, ºÎ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • anterior part of pons basilar part of pons
    ´Ù¸®³ú¾ÕºÎºÐ ´Ù¸®³ú¹Ù´ÚºÎºÐ
  • Intermediate part(commissura) of bulb
    Áú¾î±Í¸Á¿ïÁß°£ºÎºÐ
  • Iridial part of retina
    ¸Á¸·È«Ã¼ºÎºÐ
  • Iridic part of retina
    ¸Á¸·È«Ã¤[Á¶¸®°³]ºÎºÐ
  • Laibal part
    ÀÔ¼úºÎºÐ
  • Lateral(part of) globus pallidus
    °¡ÂÊâ¹éÇÙ
  • abdominal part
    ¹èºÎºÐ
  • alisphenoidal part
    ³ªºñ»À³¯°³ºÎºÐ
  • alveolar part
    Ä¡Á¶ºÎ(öÍðËÝ»).
  • alveolar part
    ÀÌÆ²ºÎºÐ
  • annular part of digital fibrous sheath
    ¼¶À¯Áý°í¸®ºÎºÐ
  • anterior part
    ¾ÕºÎºÐ
  • anterior part crus cerebri
    ¾ÕºÎºÐ ´ë³ú¼¶À¯´Ù¸®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • anterior part of pons basilar part of pons
    ´Ù¸®³ú¾ÕºÎºÐ ´Ù¸®³ú¹Ù´ÚºÎºÐ
  • corticomedial part olfactory part
    °ÑÁú¾ÈÂʺκÐ
  • intermediate part red part
    Áß°£ºÎºÐ
  • abdominal part
    ¹èºÎºÐ
  • alar part
    ¹æ¿ïºÎºÐ
  • alisphenoidal part
    ³ªºñ»À³¯°³ºÎºÐ
  • alveolar part
    Ä¡Á¶ºÎ(öÍðËÝ»).
  • alveolar part
    ÀÌÆ²ºÎºÐ
  • annular part of digital fibrous sheath
    ¼¶À¯Áý°í¸®ºÎºÐ
  • anterior part
    ¾ÕºÎºÐ
  • anterior part crus cerebri
    ¾ÕºÎºÐ ´ë³ú¼¶À¯´Ù¸®
  • anterior tibiotalar part
    ¾ÕÁ¤°­¸ñ¸»ºÎºÐ
  • aryepiglottic part
    ¸ð»Ôµ¤°³ºÎºÐ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Corticomedial part [Olfactory part]
    °ÑÁú¾ÈÂʺκÐ
    [¿¾ ¿ë¾î] ÇÇÁú³»ÃøºÎ
  • Anterior part of pons [Basilar part of pons]
    ´Ù¸®³ú¾ÕºÎºÐ [´Ù¸®³ú¹Ù´ÚºÎºÐ]
    [¿¾ ¿ë¾î] ±³ÀúºÎ
  • Intermediate part [Red part]
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Transverse part
    °¡·ÎºÎºÐ
    [¿¾ ¿ë¾î] ȾºÎ
  • Thoracic part
    °¡½¿ºÎºÐ
    [¿¾ ¿ë¾î] ±â°üºÎ
  • Thoracic part
    °¡½¿ºÎºÐ
    [¿¾ ¿ë¾î] ÈäºÎ
  • Marginal part
    °¡ÀåÀÚ¸®ºÎºÐ
    [¿¾ ¿ë¾î] ¿¬ºÎ
  • Lateral part
    °¡ÂʺκÐ
    [¿¾ ¿ë¾î] ¿ÜÃøºÎ
  • Lateral part
    °¡ÂʺκÐ
    [¿¾ ¿ë¾î] ÃøºÎ
  • Lateral (part of) globus pallidus
    °¡ÂÊâ¹éÇÙ
    [¿¾ ¿ë¾î] ¿ÜÃø´ãⱸ
  • Corneoscleral part
    °¢¸·°ø¸·ºÎºÐ
    [¿¾ ¿ë¾î] °¢¸·°ø¸·ºÎ
  • Costal part
    °¥ºñºÎºÐ
    [¿¾ ¿ë¾î] ´Á°ñºÎ
  • Tuberal part
    °áÀýºÎºÐ
    [¿¾ ¿ë¾î] °áÀýºÎ
  • Postsulcal[Posterior] part
    °í¶ûµÚºÎºÐ
    [¿¾ ¿ë¾î] ±¸ÈĺÎ
  • Presulcal[Anterior] part
    °í¶û¾ÕºÎºÐ
    [¿¾ ¿ë¾î] ±¸ÀüºÎ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • part
    ºÎ, ºÎºÐ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PP   1) Presenting Part
  2) Plasma-Pheresis
  3) Pancreatic Polype...
BMAD Medicare Part B Annual Data [file]
CAP camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab...
PT pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t...
pt part; patient; pint; point
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ASPS Alveolar soft part sarcoma
IMHV intermediate part of the medial hyperstriatum ventrale
p.p.b. part per billion
ppt part per trillion
CES-D Center for Epidemiologic Studies - Depression
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 28117
    JournalTitle: The Dhaka University studies. Part B.
    MedAbbr: Dhaka Univ Stud B Biol Stud
    ISSN: 0259-7365
    ESSN:
    IsoAbbr:
    NlmId: 9885508
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • affected part
    ÀÌȯºÎ
  • alisphenoidal part
    ³ªºñ»À ³¯°³ ºÎºÐ
  • alveolar part
    Ä¡Á¶ºÎ
  • alveolar soft part
    Æ÷»ó ¿¬Á¶Á÷
  • anterior part of pons
    ´Ù¸®³ú ¾ÕºÎºÐ
  • apex of petrous part
    ¹ÙÀ§³¡, Ãßü÷
  • basal part
    ¹Ù´Ú ºÎºÐ
  • basilar part
    ¹Ù´Ú ºÎºÐ
  • basioccipital part
    µÚÅë¼ö»À ¹Ù´Ú ºÎºÐ
  • basisphenoidal part
    ³ªºñ»À ¹Ù´Ú ºÎºÐ
  • basolateral part
    ¹Ù´Ú°¡ÂÊ ºÎºÐ
  • blind part of retina
    ¸Á¸·ºñ½Ã°¢ ºÎºÐ
  • body part
    ¸öÅë ºÎºÐ
  • bony part
    »À ºÎºÐ
  • cartilaginous part
    ¹°··»À ºÎºÐ, ¿¬°ñ ºÎºÐ
    ¿¬°ñÀÇ °¢Á¾ ÇØºÎÇÐÀû ±¸Á¶ÀÇ ´Ù¸¥ ºÎºÐÀÇ ¸í Ī.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hospitals, university Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research.
(12 Dec 1998)
university Origin: OE. Universite, L. Universitas all together, the whole, the universe, a number of persons associated into one body, a society, corporation, fr. Universus all together, universal: cf. F. Universite. See Universe.
1. The universe; the whole.
2. An association, society, guild, or corporation, especially. One capable of having and acquiring property. "The universities, or corporate bodies, at Rome were very numerous. There were corporations of bakers, farmers of the revenue, scribes, and others." (Eng. Cyc)
3. An institution organised and incorporated for the purpose of imparting instruction, examining students, and otherwise promoting education in the higher branches of literature, science, art, etc, empowered to confer degrees in the several arts and faculties, as in theology, law, medicine, music, etc. A university may exist without having any college connected with it, or it may consist of but one college, or it may comprise an assemblage of colleges established in any place, with professors for instructing students in the sciences and other branches of learning. "The present universities of Europe were, originally, the greater part of them, ecclesiastical corporations, instituted for the education of churchmen . . . What was taught in the greater part of those universities was suitable to the end of their institutions, either theology or something that was merely preparatory to theology." (A. Smith)
From the Roman words universitas, collegium, corpus, are derived the terms university, college, and corporation, of modern languages; and though these words have obtained modified significations in modern times, so as to indifferently applicable to the same things, they all agree in retaining the fundamental signification of the terms, whatever may have been added to them. There is now no university, college, or corporation, which is not a juristical person in the sense above explained [see def. 2, above]; wherever these words are applied to any association of persons not stamped with this mark, it is an abuse of terms.
Source: Websters Dictionary
(01 Mar 1998)
retrospective studies Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
(12 Dec 1998)
pharmalogical studies <pharmacology> Studies to assess the potential harmful or other effects of drugs
(16 Dec 1997)
clinical studies <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product.
(14 Nov 1997)
cohort studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
(12 Dec 1998)
combination studies <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs.
(09 Jan 1998)
multicenter studies Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
(12 Dec 1998)
multivariate studies The use of statistical techniques for the simultaneous investigations of the influence of several variables.
(05 Mar 2000)
preclinical studies <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application.
(14 Nov 1997)
sampling studies Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.
(12 Dec 1998)
prospective studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
(12 Dec 1998)
his bundle studies <cardiology> This test studies the electrical activity of the bundle of HIS.
The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement.
The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs.
This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist.
(27 Sep 1997)
immunofluorescent studies <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration.
(27 Sep 1997)
intervention studies Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • International Institute for Strategic Studies
    (¿µ)±¹Á¦ Àü·«¿¬±¸¼Ò(I.I.S.S)
  • peace studies
    ÆòÈ­ ¿¬±¸(°­ÁÂ)
  • university
    ´ëÇÐ
  • Cambridge University
    ÄÉÀӺ긮Áö ´ëÇÐ(¿µ±¹ÀÇ ´ëÇÐ,12¼¼±â¿¡ ⸳)
  • Open University
    ¿µ±¹ÀÇ ¹æ¼Û ´ëÇÐ
  • State university
    ÁÖ¸³ ´ëÇÐ
  • bluebrick university
    ÀüÅëÀִ´ëÇÐ
  • free university
    (´ëÇÐÀÇ) ÀÚÁÖ °­ÁÂ;ÀÚÀ¯ ´ëÇÐ
  • university
    ´ëÇÐ;Á¾ÇÕ´ëÇÐ
  • for my part
    ³ª¿¡ °üÇÑ ÇÑ
  • part
    ºÎºÐ,¿ªÇÒ,Ãø¸é,³ª´©´Ù
  • play a part
    ¿ªÇÒÀ» ÇÏ´Ù
  • take part in ~
    ~¿¡ Âü°¡ÇÏ´Ù
  • take the part of
    -ÀÇ ÆíÀ» µé´Ù
  • character part
    ¼º°Ý¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á